Data Vantage | KoinWorks, MiCare, Kozystay, SmartFunding and Nalagenetics bag capital

Edition #313, 03 October 2023

Share As a free subscriber, you’re reading a redacted version of DealStreetAsia’s premium DATA VANTAGE twice-weekly newsletter. Unlock access to the complete version by picking up any of our premium subscription plans.

Dear *|IF:FNAME|**|FNAME|*,*|ELSE:|*Reader,

Indonesian digital lender KoinWorks issued shares worth [redacted] million to investors, including Saison Capital, last week.

The share allotment is part of a new Series D round, per the startup’s regulatory filings. Lead investor Saison Capital has so far contributed [redacted] million to the financing.

Other entities to receive new shares last week include a special purpose vehicle (SPV) owned by [redacted] and another vehicle backed by Karen Darmono Kweefanus.

KoinWorks, which provides a financial platform for micro, small and micro enterprises (MSMEs), had raised $108 million in a Series C round led by MDI Ventures last year. The round comprised $43 million in equity and $65 million in debt funding.

MiCare, a medical claims administrator in Southeast Asia, has received $5.8 million from its parent company, Asian healthcare services group Zuellig Pharma.

The startup manages and administers medical claims for 50 insurers in the region that serve more than 6,500 corporate clients comprising more than 5,000 hospitals, clinics and pharmacies.

MiCare had last announced raising $60 million from the International Finance Corporation (IFC) and Mitsui & Co in 2021.

Executives at top investment, financial services firms and businesses use DATA VANTAGE to make smarter investment decisions in Asia. (See how)

Other updates from DATA VANTAGE

Indonesian proptech startup Kozystay has received [redacted] million from Cercano Management, formerly known as Vulcan Capital.

Singapore- and Silicon Valley-based biotech company Engine Biosciences received [redacted] million from SEEDS Capital. The funding is part of its Series A-3 round, per regulatory filings.

Singapore-headquartered SME financing platform SmartFunding has allotted shares worth $1.13 million to parent company ASEAN Fintech Group, the fintech arm of ASX-listed Fatfish Group, and another shareholder.

Biotech company Nalagenetics received $1.35 million last week from a vehicle understood to be linked to [redacted].

Singapore-based fintech startup BondbloX received $1 million from Beacon VC, the corporate VC arm of Thai lender Kasikornbank, last week. The latest transaction brings its Series B2 round total to [redacted] million. Other investors to have backed the financing include MassMutual Ventures Southeast Asia and Citigroup.

Qiscus, an Indonesian multichannel and in-app chat technology provider, has issued preference shares worth over $580k to investors, including PT Mensa Aktiva and Prasetia Dwidharma.

Singapore-based regenerative agriculture-focused firm RegenX issued shares worth [redacted] to Wavemaker Impact last week.

As a free subscriber, you’re reading a redacted version of DealStreetAsia’s premium DATA VANTAGE twice-weekly newsletter. Unlock access to the complete version by picking up any of our premium subscription plans. Anticipate Asia’s Rising Stars and Secure Lucrative Exits

Explore DATA VANTAGE (formerly Professional Plan), an indispensable part of an analyst’s Swiss Army Knife.

To keep pace with today’s constantly evolving markets, data must be smarter, deeper, and instantly accessible. DATA VANTAGE is our smart, continuously updated research & analytics platform featuring:

• Key financials, fundraising data, and shareholding information for over 2,500 Asian venture-backed companies registered in Singapore and Indonesia
• Up to 4 new research reports per month
• Monthly and quarterly data on private funding in SE Asia, India, and Greater China
• Twice-weekly DATA VANTAGE premium newsletter
• Alerts for monitoring companies and sectors
• 50% discount on tickets to our flagship summit
• Full access to DealStreetAsia’s premium stories and archives

Combine editorial insights with robust data & research. Gain a competitive edge in the ever-changing private capital investment landscape.

>> Curious? Read More About DATA VANTAGE << © DEALSTREETASIA 2014–2023.